Clinical trial Recruiting at 1 site Interventional Ages 18 to 30

Digital tool to help young adults quit vaping with ACT on Vaping app

Official title: ACT on Vaping: Digital Therapeutic for Young Adult Vaping Cessation

Run by Fred Hutchinson Cancer Center · NCT06909500 · Data updated 2026-11-12

A smartphone app using Acceptance and Commitment Therapy is tested to see if it helps 18-30 year-olds quit vaping, compared to a version with enhanced text support.

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexAll
Enrollment1178 (estimated)
SponsorFred Hutchinson Cancer Center
Academic / other
Locations1 site (Seattle, Washington)
StatusRecruiting
StartedMay 20, 2026
Main results expectedNovember 15, 2027
Study endsNovember 15, 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT06909500 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are 18-30 years old, current weekly e-cigarette users for at least 30 days, and have a compatible smartphone and data access.

Probably not a fit

Individuals not using smartphones or not willing to engage with a digital intervention may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests two versions of an ACT-based vaping cessation app among young adults who currently vape. Participants are randomized to Version A with text-messaging support plus incentive check-ins or Version B with incentivized check-ins only, both using the same app. Follow-up occurs at 3, 5.5, and 6 months after the intervention, with assessments of vaping status and engagement. The trial is led by Fred Hutchinson Cancer Center with NIDA as a collaborator and is conducted in Seattle, WA.

Why it matters

Potential benefit: If successful, the app could provide an accessible, digital option to support quitting vaping among young adults.

How similar studies have gone: Prior digital interventions for vaping cessation show promise, with behavioral apps and text support improving quit rates in young adults.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-30
* Current weekly user of e-cigarette product(s) for the last 30 days
* Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent)
* Experience downloading and using one or more apps on their smartphone
* Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app
* Has access to text messaging
* Has an email address
* United States (US) resident, with a US mailing address
* Willing to complete all study procedures
* Comfortable reading and writing in English

Exclusion Criteria:

* Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation)
* Member of the same household as another research participant
* Currently in prison
* Google voice number as sole phone number, due to its association with fraudulent study entry attempts
* Is ineligible per fraud prevention protocol
* Employees/family of investigator or study center

Where it's running

  • Fred Hutch/University of Washington Cancer Consortium
    Seattle, Washington, United States
    Recruiting

Study contacts

  • Principal investigator: Jaimee Heffner, PhD — Fred Hutch/University of Washington Cancer Consortium
  • Study coordinator: Jaimee Heffner, PhD
  • Email: jheffner@fredhutch.org
  • Phone: 206-667-7314

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.